Tuberculosis meningitis is the most serious extrapulmonary complicatio
n of tuberculosis and the commonest cause of death in childhood as a r
esult of tuberculosis. Appropriate treatment must be started as soon a
s a diagnosis of tuberculosis meningitis is suspected. The main aims o
f the drug treatment of tuberculosis meningitis are the eradication of
the causative organism Mycobacterium tuberculosis, the control of rai
sed intracranial pressure, and modulation of the immune processes caus
ing cerebral vasculitis and the associated exudate at the base of the
brain, Isoniazid, rifampicin (rifampin) and pyrazinamide are essential
drugs in the treatment of tuberculosis meningitis in dosages of 20 mg
/kg/day, 20 mg/kg/day and 40 mg/kg/day, respectively. Lower dosages of
isoniazid (10 mg/kg/day) and rifampicin (10 mg/kg/day) can be used if
infectious hepatitis is a recognised problem in a particular geograph
ical area, but a reduction in the dose of rifampicin may compromise it
s sterilising capacity, If it is possible that the disease is caused b
y drug-resistant organisms, the above regimen should br augmented by e
thionamide 20 mg/kg/day or streptomycin 20 to 40 mg/kg/day. Treatment
must be continued for a minimum of 6 months, but should be extended to
9 or 12 months if rifampicin cannot be used throughout and if pyrazin
amide cannot be used for the first 2 months of treatment. Hydrocephalu
s and raised intracranial pressure frequently complicate stage II and
stage III tuberculosis meningitis. In the presence of communicating hy
drocephalus, confirmed on air encephalogram by the appearance of air i
n the ventricles, furosemide (frusemide) 1 mg/kg/day and acetazolamide
100 mg/kg/day given in 6- or 8-hourly divided doses will expedite the
normalisation of intracranial pressure in the majority of cases. Vent
riculo-peritoneal shunting should be undertaken immediately in those c
hildren with non-communicating hydrocephalus, demonstrated on air ence
phalogram by the presence of air at the base of the brain but not in t
he ventricles, and in those children who do not respond satisfactorily
to medical management. Corticosteroids, in the form of prednisone or
dexamethasone, have been shown to improve both morbidity and mortality
in tuberculosis meningitis. These drugs should be given for the first
month of treatment.